1) Compound up to the standard dosage
联合用药达标量
2) drug combination
联合用药
1.
The influence of the intervention with drug combination and dosage associated with the traditional Chinese medicine injections;
联合用药和给药剂量的干预对中药注射剂安全性的影响
2.
The study on stability of using regulation insulin in drug combination;
正规胰岛素在联合用药中稳定性的观察
3.
The most frequent drugs was CCB and drug combination was prevailed.
发现降压药在本院门诊用药中占重要地位;钙拮抗剂类药物使用频率最高;联合用药情况在高血压处方中占一定比例。
3) combined therapy
联合用药
1.
,suppository and combined therapy,and new indi- cations,as prophylactic agents of schistosomiasis,feasibility of immunoregulation and tumor treatment.
药学研究主要包括栓剂和联合用药的研究。
2.
Objective To study the antihypertensive efficacy and effect of combined therapy with Telmisartan and Ramipril on cardiac function of the patients with hypertension.
目的探讨替米沙坦和雷米普利单用或联合用药的降压作用及对心脏功能的影响。
4) combination
[英][,kɔmbɪ'neɪʃn] [美]['kɑmbə'neʃən]
联合用药
1.
Combination Treatments for Diarrhea Predominant Irritable Bowel Syndrome
腹泻型肠易激综合征联合用药
2.
Antibacterial Activity of Florfenicol Combinations against E.coli Producing Extend-spetrum Beta-lactamases in Chickens
氟苯尼考联合用药对产ESBLs鸡大肠杆菌抗菌活性的影响
3.
This article reviews drug action of antiglaucoma drops,effect of preservative and combination of ophthalmologic solutions in recent published reports.
本文总结了近年来关于抗青光眼药物的作用机制和不良反应的文章,概述抗青光眼药引起的眼部非特异性炎症,分别总结了各类药物的作用机制和毒副作用,最后总结了国外关于联合用药的原则和不良反应。
5) combination therapy
联合用药
1.
Advances in preclinical studies on combination therapy of myocardial ischemia;
抗心肌缺血联合用药的实验研究进展
2.
Study on long-term toxicity of combination therapy with rhSCF and rhG-CSF in monkeys;
重组人干细胞因子与重组人粒细胞集落刺激因子联合用药的猴毒性研究
3.
Research progress of thalidomide in combination therapy for the treatment of tumor
沙利度胺联合用药抗肿瘤研究进展
6) Combined medication
联合用药
1.
Methods:The growth inhibition rate of BGC-823 cells treated with VM-26 combined with TAX,DDP,5-FU,respectively,were examined by MTT assay,and combined medication index(CI)was calculated.
目的:比较替尼泊甙(VM-26)与紫杉醇(TAX)、顺铂(DDP)、5-氟尿嘧啶(5-FU)联合用药对胃癌细胞BGC-823体外生长的抑制作用。
2.
ObjectiveTo study protective effect of combined medication with nimodipine and mannitol on injury of cerebral ischemia-reperfusion.
方法将 2 4只Wister大鼠制成脑缺血再灌注动物模型 ,随机分为尼莫地平治疗组、甘露醇治疗组和两种药物联合用药组。
3.
Methods Microdose combined medication of Captopril and Nitrendipine were used.
目的 观察卡托普利和尼群地平小量联合用药治疗高血压病的疗效。
补充资料：5FU联合用药方案
5FU联合用药方案
主要用于滋养细胞肿瘤晚期(ⅢB和Ⅳ期)病人，通常两药合用。5FU加KSM(更生霉素)或5FU加AT1258(消瘤芥)。联合用药时5FU用量减至每天每千克体重26mg左右，KSM用量为每天每千克体重6μg(一般每天用300μg)，分别溶于1000ml 5%葡萄糖溶液中，先滴5FU，完后用KSM。5FU加AT1258方案：AT1258 1次用量20～30mg，5FU每千克体重26mg，先静脉注射AT1258再滴5FU，两药合用8天为一疗程。间隔为3周。对耐药病人，如耐药原因是5FU用药量偏小，则常用5FU加KSM加AT1258三药联合应用，其剂量与二药联合方案相同。必要时三药方案与长春新碱合用，先用长春新碱1～2mg，再依次用AT1258，5FU和KSM，三药剂量不减，但疗程缩短至5～6天。疗程间隔为4周，依不良反应消退时间而定。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条